MTAA supports call for future of private health summit

13 September 2021 - The Medical Technology Association of Australia (MTAA) today supported calls from AMA President, Dr Omar Khorshid, ...

Read more →

TLV is commissioned to secure access to antibiotics

13 September 2021 - TLV, the Swedish Public Health Agency and the Medical Products Agency have been commissioned by the Government ...

Read more →

Review of the National Medicines Policy – call for submissions

30 August 2021 - The National Medicines Policy Review Committee is now welcoming submissions to support the review of the National Medicines ...

Read more →

Competition, consolidation and evolution in the pharmacy market

12 August 2021 - Implications for efforts to contain drug prices and spending. ...

Read more →

Making vaccines available to other countries before offering domestic booster vaccinations

12 August 2021 - On July 8, 2021, Pfizer and BioNTech announced they would be seeking US and European authorisation ...

Read more →

Don’t want a vaccine? Be prepared to pay more for insurance.

2 August 2021 - America’s Covid-19 vaccination rate is at around 60 percent, for ages twelve and up.  ...

Read more →

National Medicines Policy Review Committee and Terms of Reference

3 August 2021 - The National Medicines Policy has influenced a number of important strategies, frameworks and programs developed since ...

Read more →

National Medicines Policy Review will be significant for all Australians

30 July 2021 - Medicines Australia is eager to be part of a significant moment in history for Australian health ...

Read more →

Announcement of the National Medicines Policy Review Committee and Terms of Reference

30 August 2021 -  The Minister for Health has established an Expert Advisory Committee to lead the Review of the National ...

Read more →

PHARMAC releases drug wish-list to be more 'transparent' but advocates say it gives false hope

28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...

Read more →

NHS England unveils new Innovative Medicine Fund

21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...

Read more →

ICER to test principle of fair access to fairly priced pharmaceuticals

2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...

Read more →

National Medicines Policy review to begin in August 2021

24 June 2021 - The review of the National Medicines Policy will begin in August 2021. ...

Read more →

Health equity and Medicaid transformation — operationalising President Biden’s agenda

19 June 2021 - President Biden has made reforms intended to “protect and strengthen Medicaid” a centrepiece of his health policy ...

Read more →

Let's have permanently quicker drug approvals

16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...

Read more →